Quest Sells Much of Focus Affiliate to Italian Laboratory

摘要

Quest Diagnostics has engaged in a rare shedding of assets, selling a portion of its California-based Focus Diagnostics affiliate to an Italian laboratory. DiaSorin S.p.A. will pay $300 million in cash for Focus' immunodiagnostics and molecular diagnostics business, further globalizing the U.S. laboratory sector. DiaSorin will operate Focus through a new U.S. subsidiary. The deal is expected to close in the second quarter of this year. Excluded from the deal are Focus' diagnostic information service laboratory, which primarily serves the biopharmaceutical sector.